Table 3. Effects of YOBH on hindlimb weight-bearing distribution in MIA-induced osteoarthritis rats

Group	Hindlimb weight-bearing distribution (%)
	Days after MIA injection
	7	12	17	22	27	32
NC1)	100.00±7.572)	100.00±7.90	100.00±4.47	100.00±3.88	100.00±3.34	100.00±1.64
OAC	52.90±6.07*3)	59.29±3.83*	59.62±5.04*	59.74±6.15*	54.21±5.72*	57.19±7.74*
YOBH 500	54.35±11.14	58.62±14.70	59.15±11.15	62.35±13.21	58.93±12.32	62.36±9.03
YOBH 1,000	59.60±5.62	65.36±5.38#2)	67.87±4.42#	69.04±4.41#	70.12±5.70#	66.77±12.61
YOBH 2,000	62.53±2.56#	71.19±5.55#	71.88±2.13#	72.20±2.18#	65.78±6.51#	69.24±12.03

NC, normal control; OAC, osteoarthritis control; YOBH, Yeonsan Ogye bone hydrolysate (500, 1,000, 2,000 mg/kg/day); MIA, monosodium iodoacetate.
All values are mean±SD (n=6).
Statistical significance was determined by one-way ANOVA followed by Dunnett’s post hoc test. ^*p<0.05 compared to NC group; ^#p<0.05 compared to OAC group.